October 16, 2024
TOPLINE: Anti-BP180 antibody levels demonstrated a moderate to strong correlation with the severity of bullous pemphigoid (BP), in a meta-analysis highlighting the potential of anti-BP180 as […]
October 16, 2024
TOPLINE: White patients have the highest absolute risk for a second primary melanoma, while Black and Asian or Pacific Islander patients have the highest relative risk […]
October 15, 2024
TOPLINE: Vienna — Participants with type 2 diabetes who were able to stop insulin for up to 12 months after receiving the novel recellularization via electroporation […]
October 15, 2024
TOPLINE: Bright light therapy (BLT) is associated with a 41% remission rate in patients with nonseasonal depressive disorders, significantly higher than the remission rates reported with […]
October 15, 2024
TOPLINE: Genetic predisposition to gout, unfavorable lifestyle habits, and poor metabolic health are associated with an increased risk for cardiovascular disease (CVD); however, adherence to a […]
October 15, 2024
TOPLINE: About one third of adult survivors of childhood cancer experience a clinically significant or high fear that their primary cancer may recur or that they […]
October 15, 2024
TOPLINE: Deprescribing antihypertensive medications is associated with a 12% lower likelihood of cognitive decline in older nursing home residents, a new study suggests. The association was […]
October 15, 2024
TOPLINE: Tumor necrosis factor (TNF) inhibitors are associated with a reduced risk for recurrent cardiovascular events in patients with radiographic axial spondyloarthritis (axSpA) and a history […]
October 15, 2024
TOPLINE: Youths with type 1 diabetes (T1D) show lower bone accrual than expected for their age, gender, pubertal stage, lean mass accrual, and growth, with greater […]